LJ, M., KE, G., JL, R., KP, K., DR, S., & MC, W. (2013). Impact of 13-valent pneumococcal conjugate vaccine (PCV13) in a pandemic similar to the 2009 H1N1 in the United States. BMC infectious diseases, 13, 229. https://doi.org/10.1186/1471-2334-13-229
Chicago Style (17th ed.) CitationLJ, McGarry, Gilmore KE, Rubin JL, Klugman KP, Strutton DR, and Weinstein MC. "Impact of 13-valent Pneumococcal Conjugate Vaccine (PCV13) in a Pandemic Similar to the 2009 H1N1 in the United States." BMC Infectious Diseases 13 (2013): 229. https://doi.org/10.1186/1471-2334-13-229.
MLA (9th ed.) CitationLJ, McGarry, et al. "Impact of 13-valent Pneumococcal Conjugate Vaccine (PCV13) in a Pandemic Similar to the 2009 H1N1 in the United States." BMC Infectious Diseases, vol. 13, 2013, p. 229, https://doi.org/10.1186/1471-2334-13-229.